Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hypertension, Portal 3Carcinoma, Hepatocellular 3Hemangioma, Capillary 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Pancreatic Neoplasms 1Melanoma 1Liver Cirrhosis 1Hemangiosarcoma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Drug Therapy 4apatinib 3Oxaliplatin 3pemigatinib 2pembrolizumab 2cemiplimab 2avelumab 2atezolizumab 2S 1 (combination) 2Nivolumab 2Leucovorin 2Irinotecan 2Folfox protocol 2Fluorouracil 2Everolimus 2Erlotinib Hydrochloride 2Endoscopic Mucosal Resection 2Docetaxel 2Capecitabine 2CGX1321 2vandetanib 1titanium silicide 1tepotinib 1tegafur-gimeracil-oteracil 1talazoparib 1sodium thiosulfate 1selpercatinib 1rucaparib 1pralsetinib 1ponatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gastrointestinal Neoplasms × Propranolol × Clear all
NCT03245554 2018-04-09

Clinical Research on Teratment of Gastrointestinal Cancer in the Preoperative by Propranolol

Central South University

Phase EARLY_PHASE1 Unknown
80 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡